Research.Patient.info
Respiratory tract diseases research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)
This study looks at a new medicine called lunsekimig for adults with long-term stuffy nose and growths called nasal polyps. It compares lunsekimig to a dummy medicine to see if it makes symptoms better and if it's safe.
Bulgaria · Poland · Belgium - authorisedHuman Pharmacology (Phase I)- First administration to humans
Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients
This early-stage study is looking at a new way to treat lung cancer called adoptive TIL therapy. It combines this new treatment with standard chemotherapy and immunotherapy. The goal is to see if it's safe and how it works in adults with advanced non-small cell lung cancer.
Netherlands